This inventor holds 26 USPTO granted patents and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Pfizer Corporation, Vertex Pharmaceuticals, Inc.. Active years: 1998-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kent, GB (2002)
- County of Kent, GB (2003)
- Sandwich, GB (1998 - 2022)
Company Filing History:
Years Active: 1998-2025
Areas of Expertise:
Title: The Innovations of Donald Stuart Middleton: A Focus on ATR Kinase Inhibitors
Introduction: Donald Stuart Middleton, based in Sandwich, GB, is a prolific inventor with an impressive portfolio that includes 26 patents. His work primarily centers on the development of compounds aimed at inhibiting ATR protein kinase, showcasing a commitment to advancing pharmaceutical research and treatment methodologies.
Latest Patents: Among Middleton's latest inventions are several patents related to compounds useful as inhibitors of ATR kinase. These inventive compounds are designed to treat a range of diseases, disorders, and conditions. The patents encompass not only the compounds themselves but also pharmaceutically acceptable compositions containing these compounds, as well as methods for their preparation and use in various in vitro applications. The details include specific chemical formulas and conditions, highlighting the innovative nature of his research that extends to studying intracellular signal transduction pathways mediated by kinases.
Career Highlights: Middleton has achieved significant milestones in his career, working with notable companies such as Pfizer Corporation and Vertex Pharmaceuticals, Inc. His experiences at these leading pharmaceutical firms have undoubtedly contributed to his expertise in drug development and innovation.
Collaborations: Throughout his career, Middleton has collaborated with talented individuals in the field, including Nadia M. Ahmad and Dean Boyall. These partnerships have enriched his work and expanded his contributions to pharmaceutical advancements.
Conclusion: Donald Stuart Middleton exemplifies the spirit of innovation in the pharmaceutical industry through his extensive work on ATR kinase inhibitors. His numerous patents and collaborations with esteemed companies and professionals reflect his dedication to improving healthcare solutions and advancing scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile